Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Holownia
Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment of HR+, HER2- Advanced Breast Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2− Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Geburtshilfe und Frauenheilkunde
Gynecology
Midwifery
Maternity
Obstetrics
Pharmacoeconomic Analysis of Using Cyclin-Dependent Kinase 4 and 6 Inhibitors in the First Line Treatment of HR-positive HER2-negative Advanced Breast Cancer
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
Pcn337 - Hr+/Her2− Advanced Breast Cancer Treatment, Disease Progression, and Survival in Argentina, Brazil, Chile, Colombia, and Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
Breast Care
Surgery
Oncology
Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis
Scientific Reports
Multidisciplinary
Development and Clinical Effectiveness of Antiandrogens in the Treatment of Advanced Prostate Cancer
Medical Council
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology